KalkineCan PYC Therapeutics (ASX:PYC) Strengthen Its Growth Strategy With a New CFO?
Highlights PYC Therapeutics has appointed an experienced biotechnology finance executive as its new Chief Financial Officer. The appointment brings international capital markets experience, including previous NASDAQ listing expertise. Clinical development and capital management remain central to the company's long-term strategy. PYC Therapeutics Ltd (ASX:PYC) has strengthened its executive leadership with the appointment of Thomas Ulmer as Chief Financial Officer, bri...
ASX
Google News
Small Caps